Synthesis and anti-HIV activity of [d4U]-[trovirdine analogue] and [d4T]-[trovirdine analogue] heterodimers as inhibitors of HIV-1 reverse transcriptase (Q44250812)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Synthesis and anti-HIV activity of [d4U]-[trovirdine analogue] and [d4T]-[trovirdine analogue] heterodimers as inhibitors of HIV-1 reverse transcriptase	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Synthesis and anti-HIV activity of [d4U]-[trovirdine analogue] and [d4T]-[trovirdine analogue] heterodimers as inhibitors of HIV-1 reverse transcriptase (English)

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

0 references

author name string

Gavriliu D

1

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Fossey C

2

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Ciurea A

3

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Delbederi Z

4

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Sugeac E

5

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Ladurée D

6

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Schmidt S

7

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Laumond G

8

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Aubertin AM

9

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

publication date

1 January 2002

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Nucleosides, Nucleotides & Nucleic Acids

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

21

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

8-9

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

505-533

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Toward improved anti-HIV chemotherapy: therapeutic strategies for intervention with HIV infections

1 reference

https://api.crossref.org/works/10.1081%2FNCN-120015066

21 January 2018

Metabolism and mechanism of antiretroviral action of purine and pyrimidine derivatives

1 reference

https://api.crossref.org/works/10.1081%2FNCN-120015066

21 January 2018

HIV-1-specific RT inhibitors: highly selective inhibitors of human immunodeficiency virus type 1 that are specifically targeted at the viral reverse transcriptase

1 reference

https://api.crossref.org/works/10.1081%2FNCN-120015066

21 January 2018

Non-nucleoside reverse transcriptase inhibitors (NNRTIs) for the treatment of human immunodeficiency virus type 1 (HIV-1) infections: strategies to overcome drug resistance development

1 reference

https://api.crossref.org/works/10.1081%2FNCN-120015066

21 January 2018

The role of non-nucleoside reverse transcriptase inhibitors (NNRTIs) in the therapy of HIV-1 infection.

1 reference

https://api.crossref.org/works/10.1081%2FNCN-120015066

21 January 2018

Non-nucleoside reverse transcriptase inhibitors: the NNRTI boom

1 reference

https://api.crossref.org/works/10.1081%2FNCN-120015066

21 January 2018

HIV resistance to reverse transcriptase inhibitors

1 reference

https://api.crossref.org/works/10.1081%2FNCN-120015066

21 January 2018

Novel mutations in reverse transcriptase of human immunodeficiency virus type 1 reduce susceptibility to foscarnet in laboratory and clinical isolates

1 reference

https://api.crossref.org/works/10.1081%2FNCN-120015066

21 January 2018

Multiple drug resistance to nucleoside analogues and nonnucleoside reverse transcriptase inhibitors in an efficiently replicating human immunodeficiency virus type 1 patient strain

1 reference

https://api.crossref.org/works/10.1081%2FNCN-120015066

21 January 2018

Anti-human immunodeficiency virus drug combination strategies

1 reference

https://api.crossref.org/works/10.1081%2FNCN-120015066

21 January 2018

Nevirapine, zidovudine, and didanosine compared with zidovudine and didanosine in patients with HIV-1 infection. A randomized, double-blind, placebo-controlled trial. National Institute of Allergy and Infectious Diseases AIDS Clinical Trials Group P

1 reference

https://api.crossref.org/works/10.1081%2FNCN-120015066

21 January 2018

Pyridinone derivatives: specific human immunodeficiency virus type 1 reverse transcriptase inhibitors with antiviral activity

1 reference

https://api.crossref.org/works/10.1081%2FNCN-120015066

21 January 2018

Inhibition of human immunodeficiency virus type 1 infection in vitro by combination of delavirdine, zidovudine and didanosine

1 reference

https://api.crossref.org/works/10.1081%2FNCN-120015066

21 January 2018

Three-drug combination of MKC-442, lamivudine and zidovudine in vitro: potential approach towards effective chemotherapy against HIV-1.

1 reference

https://api.crossref.org/works/10.1081%2FNCN-120015066

21 January 2018

The inhibition of human immunodeficiency virus type 1 in vitro by a non-nucleoside reverse transcriptase inhibitor MKC-442, alone and in combination with other anti-HIV compounds

1 reference

https://api.crossref.org/works/10.1081%2FNCN-120015066

21 January 2018

Mechanism of inhibition of HIV-1 reverse transcriptase by nonnucleoside inhibitors.

1 reference

https://api.crossref.org/works/10.1081%2FNCN-120015066

21 January 2018

Human immunodeficiency virus reverse transcriptase substrate-induced conformational changes and the mechanism of inhibition by nonnucleoside inhibitors

1 reference

https://api.crossref.org/works/10.1081%2FNCN-120015066

21 January 2018

Structure of the binding site for nonnucleoside inhibitors of the reverse transcriptase of human immunodeficiency virus type 1

1 reference

https://api.crossref.org/works/10.1081%2FNCN-120015066

21 January 2018

Synthesis and anti-HIV activity of [AZT]-[TSAO-T] and [AZT]-[HEPT] dimers as potential multifunctional inhibitors of HIV-1 reverse transcriptase.

1 reference

https://api.crossref.org/works/10.1081%2FNCN-120015066

21 January 2018

Imidazo[1,5-b]pyridazine-d4T conjugates: synthesis and anti-human immunodeficiency virus evaluation

1 reference

https://api.crossref.org/works/10.1081%2FNCN-120015066

21 January 2018

Potential multifunctional inhibitors of HIV-1 reverse transcriptase. Novel [AZT]-[TSAO-T] and [d4T]-[TSAO-T] heterodimers modified in the linker and in the dideoxynucleoside region

1 reference

https://api.crossref.org/works/10.1081%2FNCN-120015066

21 January 2018

Synthesis and evaluation of "AZT-HEPT", "AZT-pyridinone", and "ddC-HEPT" conjugates as inhibitors of HIV reverse transcriptase

1 reference

https://api.crossref.org/works/10.1081%2FNCN-120015066

21 January 2018

Crystal structure at 3.5 A resolution of HIV-1 reverse transcriptase complexed with an inhibitor

1 reference

https://api.crossref.org/works/10.1081%2FNCN-120015066

21 January 2018

Preparation and anti-HIV activity of N-3-substituted thymidine nucleoside analogs.

1 reference

https://api.crossref.org/works/10.1081%2FNCN-120015066

21 January 2018

Phenethylthiazolethiourea (PETT) compounds, a new class of HIV-1 reverse transcriptase inhibitors. 1. Synthesis and basic structure-activity relationship studies of PETT analogs

1 reference

https://api.crossref.org/works/10.1081%2FNCN-120015066

21 January 2018

The PETT series, a new class of potent nonnucleoside inhibitors of human immunodeficiency virus type 1 reverse transcriptase

1 reference

https://api.crossref.org/works/10.1081%2FNCN-120015066

21 January 2018

Phenethylthiazolylthiourea (PETT) compounds as a new class of HIV-1 reverse transcriptase inhibitors. 2. Synthesis and further structure-activity relationship studies of PETT analogs

1 reference

https://api.crossref.org/works/10.1081%2FNCN-120015066

21 January 2018

Structure-based design of N-[2-(1-piperidinylethyl)]-N'-[2-(5-bromopyridyl)]-thiourea and N-[2-(1-piperazinylethyl)]-N'-[2-(5-bromopyridyl)]-thiourea as potent non-nucleoside inhibitors of HIV-1 reverse transcriptase

1 reference

https://api.crossref.org/works/10.1081%2FNCN-120015066

21 January 2018

Synthesis of 5-alkenylated D4T analogues via the Pd-catalyzed cross-coupling reaction

1 reference

https://api.crossref.org/works/10.1081%2FNCN-120015066

21 January 2018

Bicyclic imidazo derivatives, a new class of highly selective inhibitors for the human immunodeficiency virus type 1.

1 reference

https://api.crossref.org/works/10.1081%2FNCN-120015066

21 January 2018

Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays

1 reference

https://api.crossref.org/works/10.1081%2FNCN-120015066

21 January 2018

Mononucleoside phosphotriester derivatives with S-acyl-2-thioethyl bioreversible phosphate-protecting groups: intracellular delivery of 3'-azido-2',3'-dideoxythymidine 5'-monophosphate

1 reference

https://api.crossref.org/works/10.1081%2FNCN-120015066

21 January 2018

Phase 1 study of combination therapy with L-697,661 and zidovudine. The ACTG 184 Protocol Team

1 reference

https://api.crossref.org/works/10.1081%2FNCN-120015066

21 January 2018

Rational design and synthesis of phenethyl-5-bromopyridyl thiourea derivatives as potent non-nucleoside inhibitors of HIV reserve transcriptase

1 reference

https://api.crossref.org/works/10.1081%2FNCN-120015066

21 January 2018

Identifiers

10.1081/NCN-120015066

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44250812&oldid=2108911788"